docetaxel anhydrous has been researched along with Infections, Reoviridae in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayoub, JP; Blais, N; Bradbury, PA; Feilotter, H; Goffin, JR; Goss, G; Gregg, RW; Hao, D; Keith, BD; Korpanty, GJ; Kuruvilla, S; Laurie, SA; Lee, C; Leighl, N; Mates, M; Melosky, BL; Morris, DG; Nicholas, G; Rothenstein, J; Sederias, J; Seymour, L; Shepherd, FA; Tehfe, M; Torri, V; Tu, D | 1 |
1 trial(s) available for docetaxel anhydrous and Infections, Reoviridae
| Article | Year |
|---|---|
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Mammalian orthoreovirus 3; Middle Aged; Oncolytic Virotherapy; Oncolytic Viruses; Pemetrexed; Recurrence; Reoviridae Infections; Salvage Therapy; Young Adult | 2018 |